APA (7th ed.) Citation

Verderosa, A. D., Dhouib, R., Hong, Y., Anderson, T. K., Heras, B., & Totsika, M. (2021). A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Nature Portfolio.

Chicago Style (17th ed.) Citation

Verderosa, Anthony D., Rabeb Dhouib, Yaoqin Hong, Taylah K. Anderson, Begoña Heras, and Makrina Totsika. A High-throughput Cell-based Assay Pipeline for the Preclinical Development of Bacterial DsbA Inhibitors as Antivirulence Therapeutics. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Verderosa, Anthony D., et al. A High-throughput Cell-based Assay Pipeline for the Preclinical Development of Bacterial DsbA Inhibitors as Antivirulence Therapeutics. Nature Portfolio, 2021.